Allworth Financial’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.19K | Sell |
413
-132
| -24% | -$3.15K | ﹤0.01% | 3567 |
|
|
2025
Q4 | $14.6K | Sell |
545
-44
| -7% | -$1.05K | ﹤0.01% | 3012 |
|
|
2025
Q3 | $12.6K | Buy |
589
+330
| +127% | +$7.8K | ﹤0.01% | 2997 |
|
|
2025
Q2 | $5.59K | Buy |
259
+39
| +18% | +$725 | ﹤0.01% | 3204 |
|
|
2025
Q1 | $3.26K | Buy |
220
+26
| +13% | +$472 | ﹤0.01% | 3002 |
|
|
2024
Q4 | $3.46K | Buy |
194
+165
| +569% | +$2.66K | ﹤0.01% | 2925 |
|
|
2024
Q3 | $447 | Hold |
29
| – | – | ﹤0.01% | 3443 |
|
|
2024
Q2 | $515 | Sell |
29
-62
| -68% | -$1K | ﹤0.01% | 3367 |
|
|
2024
Q1 | $1.68K | Hold |
91
| – | – | ﹤0.01% | 2875 |
|
|
2023
Q4 | $2.85K | Hold |
91
| – | – | ﹤0.01% | 2516 |
|
|
2023
Q3 | $1.9K | Hold |
91
| – | – | ﹤0.01% | 2566 |
|
|
2023
Q2 | $2.18K | Hold |
91
| – | – | ﹤0.01% | 2450 |
|
|
2023
Q1 | $1.71K | Buy |
+91
| New | +$1.73K | ﹤0.01% | 2467 |
|
|
2022
Q4 | – | Sell |
-820
| Closed | -$13K | – | 2984 |
|
|
2022
Q3 | $13K | Buy |
820
+729
| +801% | +$11.8K | ﹤0.01% | 1464 |
|
|
2022
Q2 | $1K | Sell |
91
-997
| -92% | -$18.6K | ﹤0.01% | 2064 |
|
|
2022
Q1 | $26K | Buy |
1,088
+13
| +1% | +$315 | ﹤0.01% | 1135 |
|
|
2021
Q4 | $25K | Buy |
1,075
+984
| +1,081% | +$19.8K | ﹤0.01% | 1025 |
|
|
2021
Q3 | $2K | Hold |
91
| – | – | ﹤0.01% | 1649 |
|
|
2021
Q2 | $2K | Hold |
91
| – | – | ﹤0.01% | 1348 |
|
|
2021
Q1 | $2K | Sell |
91
-121
| -57% | -$5.33K | ﹤0.01% | 1278 |
|
|
2020
Q4 | $11K | Buy |
+212
| New | +$10.5K | ﹤0.01% | 804 |
|
Other funds holding ACAD
BBA
VPM
RI
VCM
PAI